Skip to main content
. 2018 Dec 27;10(9):95–106. doi: 10.4240/wjgs.v10.i9.95

Table 1.

Cytokines involved in cachexia, function, and specific targeted therapies

Cytokine Function Drug
TGF-β Decreases protein synthesis; increases muscle catabolism Trabedersen (binds TGF-β mRNA)
TNF-α Generates radical oxygen species; increases ubiquitin-proteasome activity Infliximab (anti-TNF-α mAb); etanercept (recombinant TNF-αR); thalidomide/lenalidomide (inhibits TNF-α); pentoxifylline (inhibits TNF-α)
IL-6 Mediates systemic inflammation; increases muscle catabolism; regulates synthesis of acute phase reactants Clazakizumab (anti-IL-6 mAb ); tocilizumab (anti-IL-6 receptor mAb)

TGF-β: Transforming growth factor-beta; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-alpha.